GLP-1 Receptor Agonist Safety: Counterfeit Drug Risks
Comments Off on GLP-1 Receptor Agonist Safety: Counterfeit Drug Risks
June 14, 2026
Counterfeit GLP-1 medications present serious safety risks including inconsistent dosing and contamination. These unauthorized products can cause adverse events and treatment failures. Clinicians must counsel patients on obtaining GLP-1 drugs from…
Understanding the Risks of Counterfeit Semaglutide and Fake Ozempic Pills
Comments Off on Understanding the Risks of Counterfeit Semaglutide and Fake Ozempic Pills
April 13, 2026
Semaglutide counterfeit risks are rising with the proliferation of fake Ozempic pills in unregulated markets. These products pose significant safety concerns due to lack of FDA oversight. Clinicians must be vigilant in screening patients sourcing…